Announcements

Volume 4, Issue 1, March 2023

2022-12-15

Dear Authors,

JPADR is inviting manuscripts related to an adverse event of drugs, pharmacovigilance activities, drug safety, patient safety, clinical studies, case study, case series, etc. Authors across the globe are requested to submit their manuscripts and publish articles with us. The minimum time from submission to the decision is 45 days. While preparing the manuscript, an author should follow the instructions provided on the website.

Note: There are no article processing charges for this March issue. The processing fees have been waived.

Thank you !!!

Read more about Volume 4, Issue 1, March 2023

Current Issue

Vol 3 No 4 (2022): Journal of Pharmacovigilance and Drug Research
JPADR Vol 3 No 4

Volume 3 Issue 4

Published on-  01 December 2022.

Published: 2022-12-01

Editorial

Reviews

Research articles

Case reports

Case series

View All Issues

The Journal of Pharmacovigilance and Drug Research (JPADR) is the official publication of the Global Pharmacovigilance Society. This is an international, open access, and peer-reviewed scientific journal. It focuses on pharmacovigilance studies and their associated topics such as adverse drug reaction, drug clinical trials, drug effectiveness and efficacy, drugs risk management, as well as all aspects related to the safe use of drugs.

The JPADR is oriented to researchers, professors, students, and practitioners from both the pharmaceutical industry sector, as well as the wide range of health and medicine arenas. The journal’s objective is to establish a formal platform for communicating the research results on pharmacovigilance.

An official publication of Global Pharmacovigilance Society

“A goal towards patient safety and drug safety”

 

Abstracting and Indexing: National Digital Library of India, Google Scholar, Geneva foundation for medical education and research, J-Gate, ResearchBib, EuroPub, Zenodo, OpenAIRE, and more.

Contact: editor@jpadr.com/ editor.jpadr@gmail.com

Editor-in-Chief: Dr.Chinmaya Mahapatra, M.Pharm, Ph D.